- « Previous
- Clinical Pharmacology
- Next »
Minocin Capsules
Clinical Pharmacology
Minocin Capsules
Susceptibility testing should be performed with tetracycline since it predicts susceptibility to minocycline. However, certain organisms (eg, some staphylococci and Acinetobacter species) may be more susceptible to minocycline and doxycycline than to tetracycline.
Dilution techniques
Quantitative methods are used to determine antimicrobial minimal inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on a dilution method (Ref1, Ref30 (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of tetracycline powder. The MIC values should be interpreted according to the following criteria:
For testing aerobic gram-negative microorganisms (Enterobacteriaceae), Acinetobacter species and Staphylococcus aureus:
| MIC (µg/mL) | Interpretation |
| ≤ 4.0 | Susceptible (S) |
| 8.0 | Intermediate (I) |
| ≥ 16.0 | Resistant (R) |
| For testing Haemophilus influenzae2 and Streptococcus pneumoniae3: | |
| MIC (µg/mL) | Interpretation |
| ≤ 2.0 | Susceptible (S) |
| 4.0 | Intermediate (I) |
| ≥ 8.0 | Resistant (R) |
| 2 These interpretative standards are applicable
only to broth microdilution susceptibility testing with Haemophilus influenzae
using Haemophilus Test Medium.Ref1 3 These interpretative standards are applicable only to broth microdilution susceptibility testing using cation- adjusted Muller-Hinton broth with 2-5% lysed horse blood.1 |
|
For testing Neisseria gonorrhoeae4:
| MIC (µg/mL) | Interpretation |
| ≤ 0.25 | Susceptible (S) |
| 0.5-1.0 | Intermediate (I) |
| ≥ 2.0 | Resistant (R) |
| 4 These interpretative standards are applicable only to agar dilution susceptibility testing using GC agar base and 1% defined growth supplements.Ref1 | |
A report of "Susceptible" indicates that the pathogen is likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable. A report of "Intermediate" indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of "Resistant" indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.
Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard tetracycline powder should provide the following MIC values:
| Microorganism | MIC Range (µg/mL) |
| Escherichia coli ATCC 25922 | 0.5-2.0 |
| Enterococcus faecalis ATC 29212 | 8.0-32.0 |
| Staphylococcus aureus ATCC 29213 | 0.25-1.0 |
| Haemophilus influenzae ATCC 49247 | 4.0-32.0 |
| Streptococcus pneumoniae ATCC 49619 | 0.12-0.5 |
| Neisseria gonorrhoeae ATCC 49226 | 0.25-1.0 |
Diffusion techniques
Generic Name: Minocycline
- « Previous
- Clinical Pharmacology
- Next »
« Previous: Minocin Capsules - Overdosage & Contraindications
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Herbal First Aid
Herbal medicine is ancient, but only in recent years have many people started to take notice of its all natural healing powers. See more WebMD Videos »
